par Li, Qiyuan;Eklund, Aron C;Birkbak, Nicolai J;Desmedt, Christine
;Haibe-Kains, Benjamin
;Sotiriou, Christos
;Symmans, W Fraser;Pusztai, Lajos;Brunak, Søren;Richardson, Andrea L;Szallasi, Zoltan
Référence BMC bioinformatics, 12, page (310)
Publication Publié, 2011



Référence BMC bioinformatics, 12, page (310)
Publication Publié, 2011
Article révisé par les pairs
Titre: |
|
Auteur: | Li, Qiyuan; Eklund, Aron C; Birkbak, Nicolai J; Desmedt, Christine; Haibe-Kains, Benjamin; Sotiriou, Christos; Symmans, W Fraser; Pusztai, Lajos; Brunak, Søren; Richardson, Andrea L; Szallasi, Zoltan |
Informations sur la publication: | BMC bioinformatics, 12, page (310) |
Statut de publication: | Publié, 2011 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adenocarcinoma -- drug therapy -- genetics |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy -- genetics | |
Cohort Studies | |
Estrogen Receptor alpha -- metabolism | |
Female | |
Gene Expression Profiling | |
Humans | |
Lung Neoplasms -- drug therapy -- genetics | |
Neoadjuvant Therapy | |
Neoplasms -- drug therapy -- genetics | |
Ovarian Neoplasms -- drug therapy -- genetics | |
Prognosis | |
Receptor, erbB-2 -- metabolism | |
Tumor Markers, Biological -- analysis | |
Note générale: | Journal Article |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1471-2105 |
info:doi/10.1186/1471-2105-12-310 | |
info:pii/1471-2105-12-310 | |
info:scp/79960653747 | |
info:pmid/21798043 | |
PMC3155975 |